Biomarkers Market Size to Surpass USD 97.51 Billion by 2026 | With 12.1% CAGR
February 06, 2023 07:44 ET
|
Fortune Business Insights
Pune, India, Feb. 06, 2023 (GLOBE NEWSWIRE) -- The global Biomarkers Market size stood at USD 39.10 billion in 2018. The market is slated to expand USD 97.51 billion by 2026, exhibiting a CAGR of...
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 08, 2022 16:10 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Dec. 08, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
With 13% of CAGR, Neurological Biomarker Market to Gain $14+ Billion Revenue by 2027 | Exclusive Report by The Insight Partners
November 14, 2022 06:58 ET
|
The Insight Partners
New York, Nov. 14, 2022 (GLOBE NEWSWIRE) -- According to The Insight Partners latest study on "Neurological Biomarker Market Size, Share, Growth, Trends and Forecast to 2027 – COVID-19 Impact and...
Cancer Biomarkers Market Size & Share to Surpass $31.8 Bn by 2028 | Vantage Market Research
November 10, 2022 11:49 ET
|
Vantage Market Research
WASHINGTON, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The global Cancer Biomarkers Market was valued at $12.1 Billion in 2021 and is expected to reach $31.8 Billion by 2028, registering a CAGR of 17.5%...
Biomarkers Market Size Worth USD 88,605.25 Million by 2030 at 10.80% CAGR - Report by Market Research Future (MRFR)
October 28, 2022 09:30 ET
|
Market Research Future
New York, USA, Oct. 28, 2022 (GLOBE NEWSWIRE) -- Biomarkers Market Overview: According to a Comprehensive Research Report by Market Research Future (MRFR), “Biomarkers Market Information by...
Elixiron Immunotherapeutics Receives Grant From the Alzheimer's Association to Trial Microglia-Targeting Immunotherapy
July 12, 2022 11:01 ET
|
Elixiron Immunotherapeutics
SAN FRANCISCO, July 12, 2022 (GLOBE NEWSWIRE) -- Elixiron Immunotherapeutics, a clinical stage drug development company announced today that it has received a new grant from the Alzheimer's...
North America DNA Sequencing Market Anticipated to Garner a Revenue of $9,154 million and Grow at a Healthy CAGR of 15.9% during the Estimated Timeframe from 2019 to 2025 [200-Pages] | Revealed by Research Dive
June 28, 2022 09:00 ET
|
Research Dive
New York, USA, June 28, 2022 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the North America DNA Sequencing Market is envisioned to generate a revenue of $9,154 million and...
Global Digital Biomarkers Market is set to witness a significant CAGR of 35% from 2021 to 2026
May 16, 2022 09:30 ET
|
Medi-Tech Insights
Brussels, Belgium, May 16, 2022 (GLOBE NEWSWIRE) -- Description: Digital biomarkers are indexes that use data from digital platforms such as smartphones and wearable devices to objectively...
Standard BioTools Announces First Quarter 2022 Financial Results
May 05, 2022 16:02 ET
|
Standard BioTools Inc.
SOUTH SAN FRANCISCO, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – unleashing tools to accelerate breakthroughs in human health – today...
Neuronascent Releases Further Positive Results of NNI-362 in A Randomized Phase 1a Trial for Alzheimer’s Disease
March 30, 2022 06:00 ET
|
Neuronascent, Inc.
ROCKVILLE, Md., March 30, 2022 (GLOBE NEWSWIRE) -- Neuronascent Inc., is a clinical-stage pharmaceutical company discovering and developing novel regenerative therapies for age-related brain...